Dergiler / Clinical and Experimental Health Sciences / 2020 / Cilt: 10 - Sayı: 3

The Effect of algan hemostatic agent (AHA) on wound healing

Sayfa
279–284
Yayın Tarihi
2020-09-29
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

AHA may be used safely on excisional wounds.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The Algan Hemostatic Agent (AHA) is a novel herbal originated blood stopper.
📊
Temel Bulgular & Veri:Methods: In this study, 54 adult Wistar albino rats were used.
💡
Sonuç & Katkı:AHA may be used safely on excisional wounds.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Algan hemostatic agent · madecassol · wound healing

Abstract

Objective: The Algan Hemostatic Agent (AHA) is a novel herbal originated blood stopper. The aim of this study is to investigate the effect of AHA on wound healing on excisional wound model in rats. Methods: In this study, 54 adult Wistar albino rats were used. Rats were divided into 3 groups (saline, Madecassol and AHA). Each group was then divided into 3 subgroups as 3rd, 7th and 14th days. Two wounds were created in the dorsal thoracic region of the rats. One of the lesions was used for histopathological examinations and the other for hydroxyproline measurement. In order to evaluate the wound healing, wound area were measured during the whole treatment period and animals were sacrificed at the end of 3rd, 7th and 14th days and tissue samples were taken for the determination of hydroxyproline levels. Results: AHA treatment did not cause significantly difference in hydroxyproline level on days 3, 7, 14. The contraction percentage of wound area was higher in the AHA group on day 7 than control group. However, the difference was not statistically significant (p> 0.05). On days 3 and 14, no significant difference was detected in the contraction percentage of wound area between the control and AHA groups. AHA and Madecassol results of epidermis regeneration on the 14th day, neutrophil infiltration on the 7th day and edema on the 3rd, 7th and 14th days were different in terms of histopathological parameters compared to the control group. Conclusion: Despite good histological findings, AHA did not significantly accelerate wound healing. but did not adversely affect on wound healing. AHA may be used safely on excisional wounds.

🔖

Bu Makaleye Atıf Yap

AKSOY, H., SENER, A., AKAKIN, D., ŞEN, A., AKPINAR, Ö. B., ÖZCAN, G. S., ŞİMŞEK, A. K., ŞEKERLER, T., GÜZEL, Ş. E., MİDİ, A. (2020). The Effect of algan hemostatic agent (AHA) on wound healing. Clinical and Experimental Health Sciences, Cilt: 10 - Sayı: 3, 279–284. https://ajindex.com/articles/481451

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Thiruvoth FM, Mohapatra DP, Kumar D, Chittoria SRK, Nandhagopal V. Current concepts in the physiology of adult wound healing. Plast Aesthet Res 2015; 2: 250-256.
  2. Guo S, Di Pietro LA. Factors Affecting Wound Healing. J Dent Res 2010; 89(3): 219-229. Krafts KP. Tissue repair: The hidden drama. Organogenesis 2010; 6(4): 225–233.
  3. Ibrahim N, Wong SK, Mohamed IN, Mohamed N, Chin KY, Ima-Nirwana S, Shuid AN. Wound Healing Properties of Selected Natural Products. Int J Environ Res Public Health 2018; 15(11): 2360. Aksoy H, Sen A, Sancar M, Sekerler T, Akakin D, Bitis L, Uras F, Kultur S, İzzettin FV. Ethanol extract of Cotinus coggygria leaves accelerates wound healing process in diabetic rats. Pharm Biol 2016a; 54(11): 2732-2736.
  4. Aksoy H, Sancar M, Sen A, Okuyan B, Bitis L, Uras F, Akakin D, Çevik O, Kultur S, İzzettin FV. The effect of topical ethanol extract of Cotinus coggygria Scop. on cutaneous wound healing in rats. Nat Prod Res 2016b; 30(4): 452-455.
  5. Aksoy H, Çevik Ö, Şen A, Göğer F, Şekerler T, Şener A. Effect of Horse‐chestnut seed extract on matrix metalloproteinase‐1 and‐9 during diabetic wound healing. J Food Biochem 2019; 43(3): e12758. Midi A, Ekici H, Kumandas A, Durmus O, Bodic B, Tiryaki M. Balik MS, Yesilada E. Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats. Marmara Med J 2019a; 32(1): 27-32.
  6. Midi A, Kumandaş A, Ekici H, Arda S, Karahan S, Şimşek Ak, Yesilada E. Investigation of the effectiveness of algan hemostatic agent in renal venous bleeding model in rats. Eurasian J Med 2018a; 2: 129-132.
  7. Midi A, Kumandas A, Ekici H, Bayraktar F, Karapirli K, Karahan S, Turk M, Ozyurek HE. Investigation of the efficacy of algan hemostatic agent in liver laceration model in rats. Eurasian J Med Oncol 2019b; 3(1): 37–42.
  8. Midi A, Ozyurek He, Karahan S, Ekici H, Kumandas A, Turkmen I, Kocabas E, Turk M, Demirel OU, Yesilada E. Investigation of efficacy of the plant based algan hemostatic agent in hepatectomy bleeding model in rats. Eurasian J Med Inves 2018b; 2: 195-201.
  9. Hickman DA, Pawlowski Cl, Sekhon UDS, Marks J, Gupta AS. Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. Adv Mater 2018; 30(4). Kaya H, Gokdemir MT, Sogut O. Effects of folk medicinal plant extract ankaferd blood stopper on burn wound healing. Acta Med Mediterr 2013; 29: 497–502.
  10. Satar G, Cangül IT, Topal A, Oktay A, İnan K, Akgül MB. Effects of ankaferd blood stopper (ABS) a